George F. Tomossy, David N. Weisstub

Revival: Human Experimentation and Research (2003) (eBook, ePUB)

• Format: ePub

Produktbeschreibung

This title was first published in 2003: As new medical technologies and treatments develop with increasing momentum, the legal and ethical implications of research involving human participants are being called into question as never before. Human Experimentation and Research explores the philosophical foundations of research ethics, ongoing regulatory dilemmas, and future challenges raised by the rapid globalisation and corporatisation of the research endeavour. This volume brings together some of the most significant published essays in the field. The editors also provide an informative introduction, summarizing the area and the relevance of the articles chosen.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis eBooks
• Seitenzahl: 652
• Erscheinungstermin: 12. Juli 2017
• Englisch
• ISBN-13: 9781351772389
• Artikelnr.: 48859902

Autorenporträt

George F. Tomossy works at Macquarie University, Australia, and David N. Weisstub works within the Faculté de médecine, Université de Montréal, Canada

Inhaltsangabe

Contents: Series preface; Introduction: human research ethics. Part I: The
Historical and Philosophical Foundations: Philosophical reflections on
experimenting with human subjects, Hans Jonas (1969); Experimenting on
human subjects: philosophical perspectives, Ruth Macklin and Susan Sherwin
(2004); Principlism and the ethical appraisal of clinical trials, Eric M.
Meslin, Heather J. Sutherland, James V. Lavery and James E. Till; The
Nuremberg code in light of previous principles and practices in human
experimentation, David J. Rothman; Nuremberg's legacy: some ethical
reflections, James F. Childress; The controversy over retrospective moral
judgment, Allen Buchanan; Looking back and judging our predecessors, Tom L.
Beauchamp; When evil intrudes, Arthur L. Caplan; Shading the truth in
seeking informed consent for research purposes, Sissela Bok; Trust: the
fragile foundation of contemporary biomedical research, Nancy E. Kass,
Jeremy Sugarman, Ruth Faden and Monica Schoch-Spana; Questing for grails:
duplicity, betrayal and self-deception in postmodern medical research,
George J. Annas; Roles and fictions in clinical and research ethics, David
N. Weisstub. Part II: Protecting Human Subjects: Human experimentation and
human rights, Jay Katz; The social control of human biomedical research: an
overview and review of the literature, Paul R. Benson; Goodbye to all that:
the end of moderate protectionism in human subjects research, Jonathan D.
Moreno; Is national, independent oversight needed for the protection of
human subjects?, Alexander Morgan Capron; National, independent oversight:
reinforcing the safety net for human subjects research, Anna C.
Mastroianni; Regulating research for the decisionally impaired:
implications for mental health professionals, Marshall B. Kapp; Are
research ethics bad for our mental health?, Robert Michels; The reform of
adult guardianship laws: the case of non-therapeutic experimentation;
George F. Tomossy and David N. Weisstub. Part III: Risk and Responsibility:
The ethical analysis of risk, Charles Weijer; Defining and describing
benefit appropriately in clinical trials, Nancy M.P. King; What research
with stored samples teaches us about research with human subjects, David
Wendler; Uncertainty in clinical research; Robert J. Levine; Equipoise and
the ethics of clinical research, Benjamin Freedman; Equipoise, knowledge
and ethics in clinical research and practice, Richard Ashcroft; Ethical
considerations concerning treatment allocation in drug development trials,
S. Senn; When are placebo-controlled trials no longer appropriate?, Baruch
A. Brody. Part IV: Globalization and Corporation - Trust and Participation:
International research: ethical imperialism or ethical pluralism?, Ruth
Macklin; Is academic medicine for sale?, Marcia Angell; Ethical issues in
research relationships between universities and industry, James T. Rule and
Adil E. Shamoo; Uneasy alliance - clinical investigators and the
pharmaceutical industry, Thomas Bodenheimer; Ethics review for sale?
Conflict of interest and commercial research review boards, Trudo Lemmens
and Benjamin Freedman; Dealing with conflicts of interest in biomedical
research: IRB oversight as the next best solution to the abolitionist
approach, Jesse A. Goldner; Restoring and preserving trust in biomedical
research, Mark Yarborough and Richard R. Sharp; Privatized biomedical
research, public fears, and the hazards of government regulation: lessons
from stem cell research, David B. Resnik; Name index.